ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
9 hedge funds and large institutions have $73.1K invested in ZyVersa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
1
Virtu Financial
New York
|
$30K |
| 2 |
CAC
2
Cowen and Company
New York
|
$12.3K |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$9.7K |
| 4 |
CSS
4
Cubist Systematic Strategies
Stamford,
Connecticut
|
$9.05K |
| 5 |
SG
5
StoneX Group
New York
|
$3.12K |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$27 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $30K | +$30K | +344 | New |
|
|
CAC
2
Cowen and Company
New York
| $12.3K | +$12.3K | +143 | New |
|
|
TSS
3
Two Sigma Securities
New York
| $9.7K | +$9.7K | +113 | New |
|
|
CSS
4
Cubist Systematic Strategies
Stamford,
Connecticut
| $9.05K | +$9.05K | +105 | New |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $4.22K | +$86 | +1 | +2% |
|
|
WAG
6
Winthrop Advisory Group
Boston,
Massachusetts
| $3.28K | – | – | – |
|
|
SG
7
StoneX Group
New York
| $3.12K | +$3.12K | +36 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $1.41K | +$265 | +3 | +23% |
|
|
9
Wells Fargo
San Francisco,
California
| $27 | -$54 | – | – |
|
10
Bank of America
Charlotte,
North Carolina
| $24 | – | – | – |
|
|
11
Goldman Sachs
New York
| – | -$200K | -296 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$6.33K | -9 | Closed |
|